Division of Plastic Surgery, Department of Surgery, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Biomaterials. 2009 Dec;30(36):6844-53. doi: 10.1016/j.biomaterials.2009.08.058. Epub 2009 Sep 26.
A series of thermosensitive copolymer hydrogels, aminated hyaluronic acid-g-poly(N-isopropylacrylamide) (AHA-g-PNIPAAm), were synthesized by coupling carboxylic end-capped PNIPAAm (PNIPAAm-COOH) to AHA through amide bond linkages. AHA was prepared by grafting adipic dihydrazide to the HA backbone and PNIPAAm-COOH copolymer was synthesized via a facile thermo-radical polymerization technique by polymerization of NIPAAm using 4,4'-azobis(4-cyanovaleric acid) as an initiator, respectively. The structure of AHA and AHA-g-PNIPAAm copolymer was determined by (1)H NMR. Two AHA-g-PNIPAAm copolymers with different weight ratios of PNIPAAm on the applicability of injectable hydrogels were characterized. The lower critical solution temperature (LCST) of AHA-g-PNIPAAm copolymers in PBS were measured as approximately 30 degrees C by rheological analysis, regardless of the grafting degrees. Enzymatic resistance of AHA-g-PNIPAAm hydrogels with 28% and 53% of PNIPAAm in 100U/mL hyaluronidase/PBS at 37 degrees C was 12.3% and 37.6% over 28 days, respectively. Equilibrium swelling ratios of AHA-g-PNIPAAm hydrogels with 28% of PNIPAAm were 21.5, and significantly decreased to 13.3 with 53% of PNIPAAm in PBS at 37 degrees C. Results from SEM observations confirm a porous 3D AHA-g-PNIPAAm hydrogel structure with interconnected pores after freeze-drying and the pore diameter depends on the weight ratios of PNIPAAm. Encapsulation of human adipose-derived stem cells (ASCs) within hydrogels showed the AHA-g-PNIPAAm copolymers were noncytotoxic and preserved the viability of the entrapped cells. A preliminary in vivo study demonstrated the usefulness of the AHA-g-PNIPAAm copolymer as an injectable hydrogel for adipose tissue engineering. This newly described thermoresponsive AHA-g-PNIPAAm copolymer demonstrated attractive properties to serve as cell or pharmaceutical delivery vehicles for a variety of tissue engineering applications.
一系列温敏共聚水凝胶,氨化透明质酸-g-聚(N-异丙基丙烯酰胺)(AHA-g-PNIPAAm),通过酰胺键连接将端接 PNIPAAm(PNIPAAm-COOH)偶联到 AHA 上合成。AHA 通过将己二酰肼接枝到 HA 主链上制备,PNIPAAm-COOH 共聚物通过使用 4,4'-偶氮双(4-氰基戊酸)作为引发剂聚合 NIPAAm 的简便热自由基聚合技术合成,分别。AHA 和 AHA-g-PNIPAAm 共聚物的结构通过(1)H NMR 确定。两种不同重量比的 PNIPAAm 的 AHA-g-PNIPAAm 共聚物在可注射水凝胶中的适用性进行了表征。通过流变分析测量,无论接枝度如何,AHA-g-PNIPAAm 共聚物在 PBS 中的低临界溶液温度(LCST)约为 30°C。在 37°C 的 100U/mL 透明质酸酶/PBS 中,具有 28%和 53%PNIPAAm 的 AHA-g-PNIPAAm 水凝胶的酶抗性分别为 12.3%和 37.6%,持续 28 天。在 37°C 的 PBS 中,具有 28%PNIPAAm 的 AHA-g-PNIPAAm 水凝胶的平衡溶胀比为 21.5,而具有 53%PNIPAAm 的水凝胶的溶胀比显著降低至 13.3。SEM 观察结果证实了冻干后具有互连孔的多孔 3D AHA-g-PNIPAAm 水凝胶结构,并且孔径取决于 PNIPAAm 的重量比。人脂肪来源干细胞(ASCs)包封在水凝胶内表明 AHA-g-PNIPAAm 共聚物无细胞毒性,并保持包封细胞的活力。初步体内研究表明,AHA-g-PNIPAAm 共聚物作为可注射水凝胶在脂肪组织工程中具有有用性。这种新描述的温敏 AHA-g-PNIPAAm 共聚物具有作为各种组织工程应用的细胞或药物输送载体的有吸引力的特性。